• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Expression of normal myeloid-associated antigens by acute leukemia cells.

作者信息

Dinndorf P A, Andrews R G, Benjamin D, Ridgway D, Wolff L, Bernstein I D

出版信息

Blood. 1986 Apr;67(4):1048-53.

PMID:2937468
Abstract

Monoclonal antibodies that react with hematopoietic cells and their precursors in a stage and lineage restricted fashion were used in indirect immunofluorescence assays to examine leukemic cells from 105 pediatric age patients. The differentiative states of blasts from 42 patients with acute nonlymphocytic leukemia (ANLL) were defined by these antibodies. When these were compared to their morphologic and histochemical levels of differentiation as defined by the French-American-British (FAB) classification, no direct relationship was found. The reactivity of these antibodies with leukemic cells from 63 patients with acute lymphocytic leukemiA (ALL) was also investigated, and the usefulness of these antibodies in distinguishing leukemias of myeloid from those of lymphoid origin was demonstrated.

摘要

相似文献

1
Expression of normal myeloid-associated antigens by acute leukemia cells.
Blood. 1986 Apr;67(4):1048-53.
2
Undifferentiated leukemia of infancy with t(11:17) chromosomal rearrangement. Coexpressing myeloid and B cell restricted antigens.
Cancer. 1987 Mar 15;59(6):1143-9. doi: 10.1002/1097-0142(19870315)59:6<1143::aid-cncr2820590618>3.0.co;2-j.
3
Acute mixed lineage leukemia: clinicopathologic correlations and prognostic significance.急性混合谱系白血病:临床病理相关性及预后意义
Blood. 1985 Nov;66(5):1115-23.
4
Immunologic classification of leukemia and lymphoma.白血病和淋巴瘤的免疫分类
Blood. 1986 Jul;68(1):1-31.
5
[Monoclonal antibodies ICO-02 to blast cell antigens in patients with chronic myeloleukemia in blast crisis].[针对急变期慢性髓性白血病患者原始细胞抗原的单克隆抗体ICO-02]
Eksp Onkol. 1984;6(5):53-5.
6
Nonspecific cross-reacting antigen in normal and leukemic myeloid cells and serum of leukemic patients.正常及白血病髓细胞和白血病患者血清中的非特异性交叉反应抗原。
Cancer Res. 1980 Jun;40(6):2039-44.
7
Expression of the non-T ALL-associated p24 antigen on leukaemic blasts from patients with ANLL.
Leuk Res. 1987;11(1):97-101. doi: 10.1016/0145-2126(87)90109-3.
8
Acute lymphoblastic leukemia in infants: evidence for B cell origin of disease by use of monoclonal antibody phenotyping.
Blood. 1986 Oct;68(4):975-8.
9
Antigenic analysis of hematopoiesis: II. Expression of human neutrophil antigens on normal and leukemic marrow cells.
Blood. 1984 Mar;63(3):574-8.
10
Cell surface markers in leukemia: biological and clinical correlations.白血病中的细胞表面标志物:生物学与临床相关性
Crit Rev Oncol Hematol. 1985;2(3):209-60. doi: 10.1016/s1040-8428(85)80003-2.

引用本文的文献

1
CAR-T cell therapy for cancer: current challenges and future directions.用于癌症治疗的嵌合抗原受体T细胞疗法:当前挑战与未来方向
Signal Transduct Target Ther. 2025 Jul 4;10(1):210. doi: 10.1038/s41392-025-02269-w.
2
Next-generation immunotherapeutic approaches for blood cancers: Exploring the efficacy of CAR-T and cancer vaccines.血液癌症的新一代免疫治疗方法:探索嵌合抗原受体T细胞(CAR-T)和癌症疫苗的疗效。
Exp Hematol Oncol. 2025 May 17;14(1):75. doi: 10.1186/s40164-025-00662-3.
3
From Chemotherapy to Targeted Therapy: Unraveling Resistance in Acute Myeloid Leukemia Through Genetic and Non-Genetic Insights.
从化疗到靶向治疗:通过遗传学和非遗传学见解解析急性髓系白血病的耐药性
Int J Mol Sci. 2025 Apr 24;26(9):4005. doi: 10.3390/ijms26094005.
4
A framework integrating multiscale in-silico modeling and experimental data predicts CD33CAR-NK cytotoxicity across target cell types.一个整合多尺度计算机模拟建模和实验数据的框架预测了CD33CAR-NK对多种靶细胞类型的细胞毒性。
bioRxiv. 2025 Jan 2:2024.12.31.630941. doi: 10.1101/2024.12.31.630941.
5
Modelling acute myeloid leukemia (AML): What's new? A transition from the classical to the modern.建模急性髓系白血病 (AML):有何新进展?从经典到现代的转变。
Drug Deliv Transl Res. 2023 Aug;13(8):2110-2141. doi: 10.1007/s13346-022-01189-4. Epub 2022 Aug 5.
6
Clinical Development and Therapeutic Applications of Bispecific Antibodies for Hematologic Malignancies.双特异性抗体在血液系统恶性肿瘤中的临床开发与治疗应用
Cancer Treat Res. 2022;183:287-315. doi: 10.1007/978-3-030-96376-7_11.
7
Emerging CAR T Cell Strategies for the Treatment of AML.治疗急性髓系白血病的新兴嵌合抗原受体T细胞策略
Cancers (Basel). 2022 Feb 27;14(5):1241. doi: 10.3390/cancers14051241.
8
Aptamers: Potential Diagnostic and Therapeutic Agents for Blood Diseases.适体:血液疾病的潜在诊断和治疗剂。
Molecules. 2022 Jan 7;27(2):383. doi: 10.3390/molecules27020383.
9
An Update on Immune Based Therapies in Acute Myeloid Leukemia: 2021 and Beyond!急性髓系白血病免疫治疗的最新进展:2021 年及以后!
Adv Exp Med Biol. 2021;1342:273-295. doi: 10.1007/978-3-030-79308-1_9.
10
LukS-PV Induces Apoptosis the SET8-H4K20me1-PIK3CB Axis in Human Acute Myeloid Leukemia Cells.LukS-PV 通过 SET8-H4K20me1-PIK3CB 轴诱导人急性髓系白血病细胞凋亡。
Front Oncol. 2021 Oct 20;11:718791. doi: 10.3389/fonc.2021.718791. eCollection 2021.